Analytics
HIMSS21
In a HIMSS21 educational session, the health system's medical director for analytics goes in-depth describing how its source-of-truth dataset and de-identified COVID-19 data repository have made an impact.
HIMSS21
Aggregating information can disguise differences in the way different groups of vulnerable people access care – and prevent organizations from taking useful action.
Five analytics companies – Aetion, Flatiron Health, IQVIA, Syapse and Tempus – are joining to advance use of data derived from EHRs, claims and other sources outside of clinical trials.
The medical facility is now reportedly seeking a HIMSS Analytics Electronic Medical Record Adoption Model (EMRAM) Stage 5 certification.
The trust's longstanding paper-light approach and digitally enhanced team were highlighted as the key components to achieving EMRAM Stage 5.
The Global Pathogen Analysis System sequences and analyses COVID-19 pathogen data in minutes, enabling scientists and governments worldwide to react faster and mitigate the risks.
SPONSORED
|
10:52 am |
May 17, 2021
|
10:52 am |
May 17, 2021
Angel Mena, MD, and Steven Rube, MD, discuss the challenges of managing and sharing patient data post-pandemic and lessons learned from the COVID-19 crisis.
Professor Karol Sikora, chief medical officer at Rutherford Health, discusses the most pressing needs in oncology today and how he envisages cancer treatment decision-making in the next decade.
Switching from letters and phone calls to automated emails and text messages made the difference, with some help from analytics.